Biomarkers and platelets in CPR patients
Part of Heart & circulation clinical trials.
This trial is studying the blood biomarkers and platelet characteristics in patients who receive CPR and are then placed on a heart-lung bypass machine (ECPR). It aims to understand how these biological markers relate to patient outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 18 and 70 years old (older may be considered if in good health).
- Your cardiac arrest must have been witnessed, with CPR started within 5 minutes.
- The cause of your cardiac arrest needs to be reversible (like a heart problem, blood clot in the lung, severe cold, poisoning, injury, or lung issues).
- After 20 minutes of standard CPR, your heart either did not restart or it restarted but could not keep beating on its own.
- You must not have active infections like hepatitis B, C, HIV, or syphilis, or blood cancers, aplastic anemia, or ITP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted approach to manage oxygen levels in the brain for patients who received ECMO (a machine that does the heart and lung work) after a cardiac arrest that did not respond to standard CPR. The goal is to improve brain recovery and outcomes.
This trial tests a treatment called ECPR, which uses a machine to pump blood and add oxygen after a cardiac arrest that doesn't respond to standard CPR and shocks. It aims to improve survival and recovery by quickly starting this support in the hospital.
This trial looks at how well CPR (chest compressions) is done during an emergency resuscitation in children and young adults. The goal is to understand what helps improve care during life-saving resuscitation.
This early safety study tests whether “hydrogen” can be given to children during emergency heart resuscitation that isn’t improving with standard efforts. It’s meant to see if the treatment is safe and feasible for a very specific, life-threatening situation.
This study looks at what helps determine survival and better brain function after people are treated with ECMO, a heart-lung support machine. It may help doctors understand who is most likely to do well after this kind of emergency treatment.
This trial tests whether giving ECMO (a heart-lung machine) to people in cardiac arrest before they reach the hospital can improve survival. It might be an option if you had a witnessed heart attack and received CPR quickly.
Hear when a new ExtraCorporeal Membrane Oxygenation (ECMO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.